The Myoguide system is designed to amplify EMG signals from muscle and provide audio feedback to assist clinicians in locating areas of muscle activity, according to the company. Treatment delivery can be in the form of neuromodulator injections to inserting a dry needle electrode.
Applications include pain management, spasticity and cosmetics.
The Myoguide system has already been in clinical use in Europe and Canada.
Related Articles on FDA Clearances:
Cytori Therapeutics Receives FDA Clearance for New Version of Puregraft System
Anulex Technologies Receives FDA Clearance for Additional Indications of fiXate Tissue Band
Spacelabs Healthcare Receives FDA 510(k) Clearance for New Anesthesia Delivery System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.